Fred Hutchinson Cancer Research Center, WA's Series 2020 Taxable Bonds Assigned 'A+' Rating - S&P Global Ratings’ Credit Research

Fred Hutchinson Cancer Research Center, WA's Series 2020 Taxable Bonds Assigned 'A+' Rating

Fred Hutchinson Cancer Research Center, WA's Series 2020 Taxable Bonds Assigned 'A+' Rating - S&P Global Ratings’ Credit Research
Fred Hutchinson Cancer Research Center, WA's Series 2020 Taxable Bonds Assigned 'A+' Rating
Published Apr 22, 2020
2 pages (1312 words) — Published Apr 22, 2020
Price US$ 150.00  |  Buy this Report Now

About This Report

  
Abstract:

SAN FRANCISCO (S&P Global Ratings) April 22, 2020--S&P Global Ratings assigned its 'A+' long-term rating to Fred Hutchinson Cancer Research Center (Fred Hutch), Wash.'s $119.8 million series 2020 taxable bonds. At the same time, we affirmed our 'A+' long-term rating on Washington Health Care Facilities Authority's series 2011A, 2015, and 2017A-2017C revenue bonds, issued for Fred Hutch, in addition to our 'A+' issuer credit rating (ICR) on Fred Hutch. The outlook on all the ratings is negative. The negative outlook reflects the potential pressure on Fred Hutch's operations driven by current and forecast economic conditions and a potential loss or delay in payments of various research grants. It also reflects our view that the potential declining investment performance and endowment

  
Brief Excerpt:

...April 22, 2020 SAN FRANCISCO (S&P Global Ratings) April 22, 2020--S&P Global Ratings assigned its 'A+' long-term rating to Fred Hutchinson Cancer Research Center (Fred Hutch), Wash.'s $119.8 million series 2020 taxable bonds. At the same time, we affirmed our 'A+' long-term rating on Washington Health Care Facilities Authority's series 2011A, 2015, and 2017A-2017C revenue bonds, issued for Fred Hutch, in addition to our 'A+' issuer credit rating (ICR) on Fred Hutch. The outlook on all the ratings is negative. The negative outlook reflects the potential pressure on Fred Hutch's operations driven by current and forecast economic conditions and a potential loss or delay in payments of various research grants. It also reflects our view that the potential declining investment performance and endowment market values along with weaker fundraising results, driven by market volatility and unfavorable economic trends, could negatively affect the ratings, although management reports that to date,...

  
Report Type:

Ratings Action

Issuer
Sector
Global Issuers, Public Finance, Structured Finance
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Fred Hutchinson Cancer Research Center, WA's Series 2020 Taxable Bonds Assigned 'A+' Rating" Apr 22, 2020. Alacra Store. May 18, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Fred-Hutchinson-Cancer-Research-Center-WA-s-Series-2020-Taxable-Bonds-Assigned-A-Rating-2416997>
  
APA:
S&P Global Ratings’ Credit Research. (). Fred Hutchinson Cancer Research Center, WA's Series 2020 Taxable Bonds Assigned 'A+' Rating Apr 22, 2020. New York, NY: Alacra Store. Retrieved May 18, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Fred-Hutchinson-Cancer-Research-Center-WA-s-Series-2020-Taxable-Bonds-Assigned-A-Rating-2416997>
  
US$ 150.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Residential Mortgage-Backed Securities from one place.